Pharmacovigilance analysis of the association between SGLT-2 inhibitors and diabetic foot infections using the FAERS database: An observational study
A strong, agent-specific signal links canagliflozin to DFI. Clinicians should prioritise foot surveillance and consider safer SGLT-2 inhibitor alternatives in high-risk patients.
Authors
- F. Liu
- Siqi Jia
- Ping Zhu
- Qingping Zeng
Institutions
- Army Medical University (CN)
- Southwest Hospital (CN)
- Tsinghua University (CN)
Publication Details
- Journal
- Diabetes Research and Clinical Practice
- Published
- 2026-01-21
- DOI
- https://doi.org/10.1016/j.diabres.2026.113109
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00